Comprehensive Long-term Follow up of Adults With Arterial Switch Operation
Key facts
- Who runs it
- University of Zurich
- Where
- Austria, France, Netherlands, Spain, and Switzerland11 sites in 5 countriesChoose a country to see its sites
- Trial code
- Status
- Active, not recruiting
- People taking part
- 540 people enrolled
- Started
- 1 Oct 2019
- Expected to end
- 30 Sept 2039
- Type of study
- Observational
- Treatments tested
- No intervention is planed
- Record updated
- 8 November 2022
Who can take part
- Age
- 16 years and older
- Sex
- Women and men
- Healthy volunteers
- Can take part
The registry criteria, word for word
Show all 4 criteriaShow less
Who can take part
- Adults (≥16 years)
- with transposition of great arteries or a Taussig-Bing anomaly
- who underwent repair by an ASO, and who are actively followed at one of the participating centers will be enrolled
Who cannot take part
- Incapability of giving informed consent and previous heart transplant
This trial has no sites in United States.
It has sites in 5 countries. Choose a country to see its sites.
About the trial
What the trial wants to find out
Background: Long-term outcomes in adults with prior arterial switch operation (ASO) have not yet been well defined. The aim of this study is to elucidate incidence and predictors of adverse cardiac outcomes in a prospectively followed cohort of adults after their ASO.
Read full original descriptionShow less
Methods: The comprehensive long-term follow up of adults with ASO is a project within the European collaboration for prospective outcome research in congenital heart disease (EPOCH). It is designed as a prospective, international multicenter cohort study. Consecutive patients (aged 16 years or more) with prior ASO will be included at 11 European tertiary care centers. Participants will be followed according to a standardized protocol following international recommendations, including standardized protocols for imaging and for exercise testing. Main outcome measures are all-cause and cardiac-related mortality, rate of cardiac re-intervention, neo-aortic dissection, myocardial infarction, stroke, infective endocarditis, sustained atrial and ventricular arrhythmias, new-onset or worsening pulmonary hypertension and new-onset heart failure. Secondary endpoints are frequency and progression of right ventricular outflow tract stenosis, neo-aortic root dilatation, neo-aortic valve regurgitation and ventricular dysfunction. The impact of demographic, anatomic (e.g. coronary artery anatomy) and functional variables on the above-mentioned outcomes, as well as quality of life and incidence of pregnancy related complications will also be assessed.
Aim: The prospective, international, multicenter EPOCH-ASO study will provide a better understanding of adverse outcomes and their predictors in adults after ASO. The results of the EPOCH-ASO study may help to optimize future care of this novel patient cohort in adult cardiology.
The group in the trial
- Arterial Switch Operation - Transposition of Great Arteries
Patients with previous arterial switch operation for the treatment of a transposition of great arteries will constitute the sole group of the cohort.
Treatment: No intervention is planed
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Comprehensive Long-term Follow up of Adults With Arterial Switch Operation - European Collaboration for Prospective Outcome Research in Congenital Heart Disease
- Publications
- Aortic coarctation and long-term morbidity after arterial switch operation: a multicentre international cohort study.Heart (British Cardiac Society), 2026
- Record updated
- 8 November 2022